logo-loader
CannPal Animal Therapeutics Ltd

CannPal Animal Therapeutics leveraged to 'lucrative potential' of growing market

CannPal Animal Therapeutics Ltd (ASX:CP1) founder and managing director Layton Mills speaks to Proactive Investors about the innovative pet pharmaceutical company, which operates in the medical cannabis space.

"The goal for the company is really to develop products that can address clear, unmet needs in the animal health market, focusing on companion animals. We have a lead drug candidate that's currently in development, that's CPAT-01, which we're developing as a pain control in dogs... we've just finished wrapping up our first Phase 1A Pharmacokinetic and Safety Study, which is a really exciting milestone for the company," says Mills.

CannPal Animal Therapeutics is simultaneously developing nutraceutical products using Cannabidiol, a less regulated cannabinoid than THC and CBD, in order to generate early revenues as the core pharmaceutical products go through the necessary approvals processes.

Quick facts: CannPal Animal Therapeutics Ltd

Price: $0.17

Market: ASX
Market Cap: $15.83 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of CannPal Animal Therapeutics Ltd named herein, including the promotion by the Company of CannPal Animal Therapeutics Ltd in any Content on the...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Musgrave Minerals signs $18 million earn-in JV with...

Musgrave Minerals Ltd (ASX:MGV) managing director Robert Waugh updates Proactive on the signing of an $18 million earn-in joint venture agreement with Evolution Mining centred on the Lake Area of the Cue Project in W.A.  Evolution can earn 75% in the area by sole funding $18 million in...

15 hours, 24 minutes ago

2 min read